Physician profile
Edward J Swanton
NPI 1407910730
$313,490.44
in general payments reported to CMS, 2019-2025
8 companies · $46K in 2025
The $46K reported for 2025 was more than what 98% of Geriatric Psychiatry providers received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $21K · 2021: $25K · 2022: $42K · 2023: $72K · 2024: $37K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125K · Consulting Fee: $17K · Travel and Lodging: $7,747 · Food and Beverage: $4,889 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124,996.91 |
| Consulting Fee | $17,385.50 |
| Travel and Lodging | $7,747.45 |
| Food and Beverage | $4,888.63 |
| Education | $119.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $170,304.08 | 2019-2024 | Nuplazid |
| Neurocrine Biosciences, INC. | $103,245.76 | 2019-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $39,409.21 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Janssen Pharmaceuticals, INC | $243.37 | 2019-2023 | Spravato |
| Allergan, INC. | $217.01 | 2019 | |
| Neuronetics, INC. | $28.38 | 2025 | Neurostar Tms Therapy System |
| Axsome Therapeutics, INC. | $23.02 | 2022 | |
| Avanir Pharmaceuticals, INC. | $19.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Swanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.